Adagene ADAG
NASDAQ ADAG
$3.58 -0.11 (-2.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Adagene (ADAG) Property, Plant & Equipment (Net) (2019 - 2026)

Analysis

Adagene (ADAG) Property, Plant & Equipment (Net) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Adagene 211.24 Mn 211.24 Mn - 716,616.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 716,616.00
Dec 31, 2025 717,374.00
Jun 30, 2025 901,383.00
Dec 31, 2024 1.13 Mn
Jun 30, 2024 1.44 Mn
Dec 31, 2023 1.84 Mn
Jun 30, 2023 2.22 Mn
Dec 31, 2022 2.78 Mn
Jun 30, 2022 3.07 Mn
Dec 31, 2021 3.49 Mn
Jun 30, 2021 2.59 Mn
Dec 31, 2020 2.07 Mn
Dec 31, 2019 1.88 Mn